BridgeMD
New treatment option for Insomnia
Official title Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
ClinicalTrials.gov ID: NCT05390918
What this study is testing
- What it's testing
- This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 11 to 18
You may be able to join if
- Inclusion:
- Nationwide Children's Hospital patients
- Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent
- Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days)
- Resides with primary caregiver who has legal authority to consent to research participation Exclusion:
See the full eligibility criteria
- Inclusion:
- Nationwide Children's Hospital patients
- Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent
- Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days)
- Resides with primary caregiver who has legal authority to consent to research participation Exclusion:
- Suicide attempt in the past 3 months
- Diagnosis of Bipolar Disorder or Psychosis
- Having a change to an antipsychotic and/or mood stabilizer medication regimen within the last 2 months
- Snoring at least 3 nights per week that can be heard a room or two away, even without a cold or flu or during allergy season
- Gasping for air while sleeping, diagnosis of Obstructive Sleep Apnea, or turning blue within the past year
- Body Mass Index \> 40
- Daytime symptoms of Restless Leg Syndrome
- Diagnosis of Narcolepsy
- Diagnosis of Seizures or Epilepsy, or prescribed anticonvulsant medication, within the past 4 years
- Significant substance use in the past month
- Currently receiving sleep disorder services from a sleep clinic
- Inability to speak/read English adequately to understand and complete study consent and procedures
- No access to a telephone or internet-connecting device
- Sibling already in the study
The study team makes the final eligibility decision.
Where it's taking place
- Columbus, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 11 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Columbus, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.